These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6316649)

  • 21. Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C.
    Johnson DC; McDermott MR; Chrisp C; Glorioso JC
    J Virol; 1986 Apr; 58(1):36-42. PubMed ID: 3005656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurovirulence of an herpes simplex type 1 thymidine kinase negative mutant determined by virus biochemical defect and host immune system in mice. Brief report.
    Gordon YJ; Simon PL; Armstrong JA
    Arch Virol; 1984; 80(2-3):225-9. PubMed ID: 6326711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of genital herpes simplex virus infection in mice. III. Comparison of the virulence of wild and mutant strains.
    Schneweis KE; Forstbauer H; Olbrich M; Tag M
    Med Microbiol Immunol; 1984; 173(4):187-96. PubMed ID: 6096684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus type 1 DNA sequences which direct spread of virus from cornea to central nervous system.
    Oakes JE; Gray WL; Lausch RN
    Virology; 1986 Apr; 150(2):513-7. PubMed ID: 3008422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virulence is not conserved in recombinants between herpes simplex virus types 1 and 2.
    Halliburton IW; Honess RW; Killington RA
    J Gen Virol; 1987 May; 68 ( Pt 5)():1435-40. PubMed ID: 3033143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
    Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
    J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system.
    Sunstrum JC; Chrisp CE; Levine M; Glorioso JC
    Virus Res; 1988 Aug; 11(1):17-32. PubMed ID: 2845681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of the thymidine kinase genes of type 1 and type 2 herpes simplex viruses using intertypic recombinants.
    Halliburton IW; Morse LS; Roizman B; Quinn KE
    J Gen Virol; 1980 Aug; 49(2):235-53. PubMed ID: 6255066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice.
    Field HJ; Wildy P
    J Hyg (Lond); 1978 Oct; 81(2):267-77. PubMed ID: 212476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1.
    Meignier B; Longnecker R; Mavromara-Nazos P; Sears AE; Roizman B
    Virology; 1988 Jan; 162(1):251-4. PubMed ID: 2827384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that the gene for herpes simplex virus type 1 DNA polymerase accounts for the capacity of an intertypic recombinant to spread from eye to central nervous system.
    Day SP; Lausch RN; Oakes JE
    Virology; 1988 Mar; 163(1):166-73. PubMed ID: 2831653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurovirulence of individual plaque stocks of Herpes simplex virus type 2 strain HG 52.
    Taha MY; Brown SM; Clements GB
    Arch Virol; 1988; 103(1-2):15-25. PubMed ID: 2850778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleotide sequences important in DNA replication are responsible for differences in the capacity of two herpes simplex virus strains to spread from cornea to central nervous system.
    Day SP; Lausch RN; Oakes JE
    Curr Eye Res; 1987 Jan; 6(1):19-26. PubMed ID: 3030643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination of herpes simplex virus types 1 and 2 cerebral infections in a rat model.
    Bergström T; Svennerholm B; Conradi N; Horal P; Vahlne A
    Acta Neuropathol; 1991; 82(5):395-401. PubMed ID: 1662855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping of the herpes simplex virus DNA sequences in three herpes simplex virus thymidine kinase-transformed cell lines.
    Leiden JM; Frenkel N; Polacek D; Rapp F
    IARC Sci Publ (1971); 1978; (24 Pt 1):473-88. PubMed ID: 221351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant.
    Wilcox CL; Crnic LS; Pizer LI
    Virology; 1992 Mar; 187(1):348-52. PubMed ID: 1310559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.
    Jones CA; Taylor TJ; Knipe DM
    Virology; 2000 Dec; 278(1):137-50. PubMed ID: 11112490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus.
    Shimotohno K; Temin HM
    Cell; 1981 Oct; 26(1 Pt 1):67-77. PubMed ID: 6276009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidine kinase deletion mutants of herpes simplex virus type 1.
    Sanders PG; Wilkie NM; Davison AJ
    J Gen Virol; 1982 Dec; 63(2):277-95. PubMed ID: 6296278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of intertypic recombinants for analysis of gene organization in herpes simplex virus.
    Morse LS; Pereira L; Roizman B; Schaffer PA
    IARC Sci Publ (1971); 1978; (24 Pt 1):41-61. PubMed ID: 221347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.